iBio (IBIO) Other Working Capital Changes (2013 - 2026)
iBio's (IBIO) quarterly Other Working Capital Changes came in at $189000.0 in Q1 2026, up 126.14% year-on-year from $83576.1 in Q1 2025, and up 200.0% on a QoQ basis from -$189000.0 in Q4 2025.
iBio (IBIO) Other Working Capital Changes (2013 - 2026) Analysis & Trends
iBio (IBIO) has 11 years of Other Working Capital Changes data on file, last reported at $189000.0 in Q1 2026.
- On a quarterly basis, Other Working Capital Changes rose 126.14% year-over-year to $189000.0 in Q1 2026; TTM through Mar 2026 was $523000.0, a 225.72% increase from a year earlier, with the FY2025 full-year figure at $250000.0, up 164.27% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at $189000.0, up from -$189000.0 in the prior quarter.
- Over the last five years, Other Working Capital Changes for IBIO reached as high as $1.3 million in Q4 2021 and fell as low as -$801000.0 in Q2 2022.
- Historically, Other Working Capital Changes has averaged -$45578.9 across 5 years, with a median of -$38000.0 in 2023.
- Across the five-year window, Other Working Capital Changes sank 3466.67% in 2024 and soared 716.13% in 2025, its largest moves.
- Year by year, Other Working Capital Changes stood at -$73000.0 in 2022, then plunged by 36.99% to -$100000.0 in 2023, then surged by 604.0% to $504000.0 in 2024, then slumped by 137.5% to -$189000.0 in 2025, then jumped by 200.0% to $189000.0 in 2026.
- Per Business Quant data, the three most recent Other Working Capital Changes figures were $189000.0 in Q1 2026, -$189000.0 in Q4 2025, and -$50000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,921.77 Bn | 66,921.49 Bn | - |
| 2 | Nanobiotix | 1,911.83 Bn | 1,911.77 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 471.57 Bn | 466.77 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.01 Bn | 114.76 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - |
| 8 | Argenx Se | 55.86 Bn | 50.68 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.48 Bn | 34.47 Bn | 959.66 Mn |
| 10 | iBio | 167.44 Mn | 167.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 189,000.00 |
| Mar 31, 2026 | 189,000.00 |
| Mar 31, 2026 | 189,000.00 |
| Dec 31, 2025 | -189,000.00 |
| Dec 31, 2025 | -189,000.00 |
| Dec 31, 2025 | -189,000.00 |
| Sep 30, 2025 | -50,000.00 |
| Sep 30, 2025 | -50,000.00 |
| Sep 30, 2025 | -50,000.00 |
| Jun 30, 2025 | 573,000.00 |
| Jun 30, 2025 | 573,000.00 |
| Jun 30, 2025 | 573,000.00 |
| Mar 31, 2025 | -723,000.00 |
| Mar 31, 2025 | -723,000.00 |
| Mar 31, 2025 | -723,000.00 |
| Dec 31, 2024 | 504,000.00 |
| Dec 31, 2024 | 504,000.00 |
| Dec 31, 2024 | 504,000.00 |
| Sep 30, 2024 | -104,000.00 |
| Sep 30, 2024 | -104,000.00 |